SMTL ID : 6hm6.1

CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH A 2-(PYRIDINYLOXYMETHYL)PYRIDINE INHIBITOR

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

monomer

Ligands

1 x GDK: 2-(4-methylphenyl)-3-(pyridin-2-ylmethoxy)pyridine(Non-covalent)

GDK.1: 12 residues within 4Å: Chain A: L.18, G.19, V.26, A.41, M.89, E.90, M.91, A.92, E.93, G.95, P.96, L.142 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.18, A:V.26, A:A.41, A:L.142 Hydrogen bonds: A:A.92

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 2 residues within 4Å: Chain A: N.186, E.227 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Barker, M.D. et al., Discovery of potent and selective Spleen Tyrosine Kinase inhibitors for the topical treatment of inflammatory skin disease. Bioorg. Med. Chem. Lett. (2018)

Release Date

2018-10-10

Peptides

SPLEEN TYROSINE KINASE: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

SPLEEN TYROSINE KINASE

Related Entries With Identical Sequence